A recent study found that patients with chronic lung conditions such as chronic obstructive pulmonary disease are more likely to be physically active when they have regular contact with healthcare professionals, support from peers, and access to organized exercise sessions.
Patients with chronic obstructive pulmonary disease (COPD) often have significantly lower levels of daily physical activity (PA) compared to healthy individuals. A recent study found that patients with chronic lung conditions are more likely to be physically active when they have regular contact with healthcare professionals, support from peers, and access to organized exercise sessions.
The study aimed to understand the factors that both facilitate and block continued PA following the completion of pulmonary rehabilitation (PR) among those with COPD in order to inform future practice and policies for support of long-term adherence to health-enhancing behavior.
“Pulmonary rehabilitation (PR) is defined as “a comprehensive intervention based on a thorough patient assessment followed by patient-tailored therapies that include, but are not limited to, exercise training, education, and behaviour change, designed to improve the physical and psychological condition of people with chronic respiratory disease and to promote the long-term adherence to health-enhancing behavior.” The key benefits of PR include clinically important improvements in dyspnoea, physical capacity, and quality of life,” explained the authors.
The review consisted of 14 studies—12 qualitative studies and 2 mixed-method design studies. Each study had collected data using either semi-structured interviews, open-ended interviews, or focus groups.
In total, 167 individuals were diagnosed with COPD across all of the studies and each person had previously completed PR. The duration of the PR among individuals ranged from 4 to 12 weeks and they attended either inpatient and outpatient PR venues or the setting was not reported. Also, data was collected either at the individuals’ home, the rehabilitation center, or a combination of both.
The assessment of the data revealed that regular contact with healthcare professionals, including feedback about their progress and achievements, is important and necessary in order to motivate people with COPD to be physically active following PR. Additionally, the researchers found that interactions with peers can provide a sense of solidarity and support after rehabilitation, while access to regular organized exercise sessions help individuals establish a routine.
"People living with COPD often tell us that they have difficulty in maintaining a physically active lifestyle,” Hayley Robinson, the leader of the study, said in a statement. "The results provide clear guidance for future research design and we hope that the research can be used to inform future strategies in the NHS to promote physical activity after pulmonary rehabilitation.”
The researchers hope that the results will help doctors provide better long-term support for people with COPD.
Reference
Robinson H, Williams V, Curtis F, Bridle C, Jones AW. Facilitators and barriers to physical activity following pulmonary rehabilitation in COPD: a systematic review of qualitative studies. [published online June 4, 2018]. NPJ Prim Care Respir Med. doi: 10.1038/s41533-018-0085-7
Ineligibility, Limitations to PR Uptake in Patients With AECOPD
October 15th 2024Two posters at the CHEST 2024 annual meeting revealed that 18% of eligible patients hospitalized with acute exacerbations of chronic obstructive pulmonary disease (AECOPD) participated in post-discharge pulmonary rehabilitation (PR), with ineligibility significantly limiting uptake.
Read More
A Pulmonologist on Why You Should Think About Respiratory Health and the Lungs
November 16th 2021On this episode of Managed Care Cast, we speak with MeiLan K. Han, MD, MS, the author of a book released this month called Breathing Lessons: A Doctor’s Guide to Lung Health. Han, a pulmonologist, gives an inside tour of the lungs and how they work, zooms out to examine the drivers of poor respiratory health, and addresses policy changes that are needed to improve lung health.
Listen
FDA Approves Dupilumab as First Biologic Treatment for COPD
September 27th 2024The FDA approved dupilumab today as the first biologic treatment for patients with uncontrolled chronic obstructive pulmonary disease (COPD) and an eosinophilic phenotype to significantly help reduce exacerbations and improve lung function.
Read More
Social Frailty Indirectly Affects Anxiety, Depression in Patients With AECOPD Through Social Support
September 11th 2024Social frailty in patients with acute exacerbations of chronic obstructive pulmonary disease (COPD) does not directly impact anxiety or depression but influences these conditions indirectly through social support.
Read More